Click here to narrow your options by answering a few questions.

Prostate Cancer
Treatment Guide™

Prostate Cancer Treatment News

 

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Radiation
Therapy

Prostatectomy

Robotic Prostatectomy

Watchful
Waiting

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Target identified for shutting down growth of prostate cancer cells
Scientists at UT Southwestern Medical Center have identified an important step toward potentially shutting down the growth of prostate cancer cells.Dr. Ralf Kittler, Assistant Professor of Pharmacology, studies ERG, a protein that facilitates the transformation of normal prostate cells into cancer cells.

Surgery better than watchful waiting for younger prostate cancer patients
A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40.

New diagnostic, treatment approach for aggressive prostate cancer suggested by cholesterol-metabolism study
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer.

Surgery over watchful waiting better for younger prostate cancer patients
A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40.

Reliable pretreatment information assists prostate cancer patients in decision-making
Men who have been diagnosed with prostate cancer need to assimilate information rapidly in order to weigh the treatment options and make informed decisions.

How enzyme functions correlate with prostate cancer progression could lead to new treatments
A University of Houston (UH) scientist and his team are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism.With approximately one out of six American men being diagnosed and nearly a quarter of a million new cases expected this year, prostate cancer is the most common malignancy among men in the U.S.

UCLA study finds robotic-assisted prostate surgery offers better cancer control
An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had...

More intensive radiotherapy is better than less for localised prostate cancer
A radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer, the 10-year results of the largest trial of its kind have shown.

Research could help improve early diagnosis of prostate cancer
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.Currently, is it difficult to distinguish between benign and aggressive malignant tumours, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety.

Enzalutamide for metastatic prostate cancer: IQWiG assessed data subsequently submitted by the manufacturer
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

Previous Prostate Cancer News More Prostate Cancer News
 
 

 
 
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Site Map